Since FSP27/CIDEC is involved in PPARγ-dependent hepatic steatosis [8], it is therefore necessary to determine whether the effects of PPARγ agonists on the formation of FL were mediated by activation of FSP27/CIDEC expression. The gene discussed is PPARG; the disease is fatty liver disease.